VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AZTAAzenta, Inc.
$25.50$1.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAZTACash Flow

Azenta, Inc. (AZTA) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow remains highly erratic, swinging from a 15.0% margin in 2025Q1 to a 3.3% margin in 2026Q2, reflecting ongoing capital intensity and working capital volatility.

AZTA Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00Sep'99Sep'98Sep'97Sep'96
Cash from Operations61.01M72.18M49.74M5.83M-466.05M149.86M37.87M90.9M73.96M96.22M39.55M43.73M53.78M54.39M36.04M87.65M27.87M-56.49M13.66M72.87M65.19M31.11M8.86M-48.33M-55.66M20.68M-13.18M5.5M1.8M-2M-2.1M
Operating CF Margin %-12.16%8.67%0.88%-83.9%29.17%9.75%11.64%11.71%18.24%7.06%7.91%11.14%12.88%6.94%12.74%4.7%-25.83%2.59%9.8%10.73%6.71%1.65%-14.07%-18.29%5.42%-4.1%5.29%1.8%-2.31%-2.32%
Operating CF Growth %34.29%45.11%752.64%101.25%-410.99%295.76%-58.34%22.89%-23.13%143.32%-9.56%-18.69%-1.12%50.92%-58.88%214.47%149.34%-513.69%-81.26%11.78%109.53%251.37%118.32%13.17%-369.08%256.97%-339.6%205.56%190%4.76%70.83%
Net Income-178.16M-55.76M-164.9M-14.64M2.13B110.75M64.85M437.42M116.46M62.61M-69.48M14.22M31.52M-2.15M136.84M128.4M59.02M-227.86M-235.95M151.47M25.93M-10.06M17.72M-185.76M-719.95M-29.66M12.75M-7.9M-18.4M800K8.5M
Depreciation & Amortization56.81M61.21M90.74M85.58M53.7M65.33M65.5M54.45M37.43M28.15M28.05M25.16M23.46M24.16M21.62M17.25M18.42M25.86M34.54M32.8M33.9M17.19M18.38M31.81M38.03M45.26M30.21M10.4M8.1M4.8M3.1M
Stock-Based Compensation17.85M20.88M14.47M9.38M10.67M27.46M16.32M20.11M19.82M17.28M11.74M12.16M10.91M7.76M8.65M6.75M6.57M5.82M8.74M8.74M8.29M2.08M08.51M1.79M000000
Deferred Taxes-30.45M-27.04M-15.89M-28.74M24.47M-17.27M-5.41M-15.16M-45.22M517K70.27M-2.17M-1.78M-2.94M-122.14M-42.72M-6.7M108.73M-4.46M-94.66M-9.4M-2.08M0-8.51M96.75M-14.05M-8.53M-3M-4.4M-200K-400K
Other Non-Cash Items230.62M95.73M122.28M-16.71M-2.62B14.8M-90.72M-411.12M-7.94M-11.64M-1.27M3.45M-24.39M-515K14.22M-383K-215K212K208.94M7.21M5.28M468K9.9M81.42M492.13M1.13M-372K-100K200K-100K100K
Working Capital Changes-35.61M-22.84M3.04M-29.04M-72.73M-51.21M-12.67M5.19M-46.59M-691K242K-9.09M14.06M28.08M-23.14M-21.66M-49.22M30.75M1.84M-32.7M1.2M23.51M-37.15M24.2M35.6M18.01M-47.24M6.1M16.2M-7.4M-13.4M
Change in Receivables-22.73M-24.56M-12.07M34.46M-31.4M-69.64M-18.75M-11.45M-29.21M-11.18M-1.8M-5.13M12.1M6.42M-784K9.92M-53.16M29.96M-841K-841K-20.47M47.92M0533K3.13M000000
Change in Inventory-3.34M-2.67M15.9M8.25M-66.63M-50.44M-13.14M-2.93M-24.36M-12.79M8.56M-5.92M9.6M15.49M5.87M-19.13M-31.34M21.78M-610K-4.47M-1.46M23.93M-17.74M19.52M8.12M10.53M-26.84M2M3.8M-5.6M-5M
Change in Payables-5.21M1.04M9.2M-14.71M-3.93M30.97M792K4.7M5.46M7.85M-5.14M8.36M-11.92M3.12M-11.18M-15.1M39.35M-10.95M-14.76M-14.76M22.51M-14.2M0-3.96M-2.49M000000
Cash from Investing-105.52M-90.46M224.74M431.38M1.47B-146.35M-22.74M211.31M-148.47M-54.19M-10.87M-17.64M-17.8M-7.15M-21.04M-84.25M-29.21M6.25M16.77M80.97M19.07M-27.64M-70.75M43.59M10.21M-153.74M-141.91M-10.6M-4.6M-8.4M-11M
Capital Expenditures-32.29M-33.86M-37.39M-39.44M-73.44M-52.8M-39.92M-23.86M-12.79M-12.92M-12.85M-16.15M-5.52M-3.63M-8.65M-6.46M-4.36M-11.34M-23.51M-20.63M-20.95M-11.7M-8.2M-13.81M-23.66M-53.65M-13.71M-19.7M-4.4M-6.4M-9.7M
CapEx % of Revenue5.41%5.7%6.52%5.93%13.22%10.28%10.28%3.06%2.02%2.45%2.29%2.92%1.14%0.86%1.67%0.94%0.74%5.18%4.47%2.78%3.45%2.52%1.53%4.02%7.78%14.06%4.27%18.96%4.4%7.41%10.73%
Acquisitions-9.69M00-386.51M2.81B-95.51M-15.74M218.94M-85.75M-44.79M-125.25M-12.67M49.74M-68.33M-9.22M-10.06M6.95M0-1M124K-41.38M00400K-16.2M-33.14M-24.4M0000
Investments-------------------------------
Other Investing9M000-4M2M-1M0200K100K985K6K177K11.53M-2.47M-1.11M1.14M1.05M1.92M130.39M281K1.29M010.15M1.02M-504K-774K9.1M-200K-2M-1.3M
Cash from Financing-963K-9.59M-659.21M-840.46M-62.76M-25.91M-27.02M-191.16M170.28M-25.92M-25.96M-34.01M-24.46M-19.48M-19.25M-3.82M1.25M1.25M-87.8M-103.2M-171.36M5.3M130.1M6.17M7.44M160.69M220.08M1.7M-4M80.1M-400K
Debt Issued (Net)-939K-985K-783K-578K-50.11M-1.99M-2.1M-165M196.05M0366K-8.83M-239K000000-1.74M-175.01M-11K-98K34K-587K152.7M-5.83M1M2.5M-100K800K
Equity Issued (Net)2.4M2.77M-658.42M-834.89M5.25M5.81M4.59M3.42M2.83M2.04M1.89M1.81M1.84M1.85M1.71M1.36M1.25M1.25M-87.8M-101.46M3.66M5.31M130.2M6.13M8.03M9.11M225.9M1.7M800K86.7M100K
Dividends Paid0000-7.49M-29.73M-29.51M-28.89M-28.29M-27.93M-27.5M-26.99M-22.88M-21.33M-20.95M-5.18M00000000000000-100K
Share Repurchases00-661.7M-838.51M00000000000000-90.19M-110.76M0000000000-300K
Other Financing-2.42M-11.38M0-4.99M-10.4M00-687K-318K-28K-708K0-3.19M000000000000-1.12M4K0-7.3M-6.5M100K
Net Change in Cash-39.58M-24.3M-363.06M-357.25M755.96M-17.19M-2.65M107.46M96.09M16.54M4.36M-13.39M11.14M28.33M-4.19M-990K-162K-50.28M-57.96M52.46M-86.69M9.18M68.28M-298K-34.94M26.6M64.84M-3.1M-7.1M80.1M-400K
Free Cash Flow28.72M38.32M12.35M-33.6M-543.48M97.05M-2.06M67.04M61.18M83.31M26.7M27.58M48.26M50.75M27.39M81.19M23.51M-67.83M-9.86M52.24M44.24M19.41M652K-62.14M-79.32M-32.97M-26.88M-14.2M-2.6M-8.4M-11.8M
FCF Margin %4.81%6.45%2.15%-5.05%-97.84%18.89%-0.53%8.59%9.69%15.79%4.76%4.99%10%12.01%5.27%11.8%3.96%-31.02%-1.87%7.03%7.28%4.19%0.12%-18.08%-26.07%-8.64%-8.37%-13.67%-2.6%-9.72%-13.05%
FCF Growth %-10.29%210.29%136.76%93.82%-659.99%4815.84%-103.07%9.58%-26.56%212.02%-3.2%-42.85%-4.91%85.34%-66.27%245.39%134.66%-588.1%-118.87%18.09%127.91%2876.99%101.05%21.66%-140.6%-22.63%-89.32%-446.15%69.05%28.81%19.18%
FCF per Share0.620.840.23-0.51-7.261.30-0.030.930.861.180.390.400.710.770.421.250.37-1.08-0.150.710.610.430.01-1.69-3.07-1.83-1.56-1.27-0.25-1.07-1.37
FCF Conversion (FCF/Net Income)-0.16x-1.29x-0.30x-0.41x1.09x1.35x0.58x3.15x0.63x1.54x-0.57x3.07x12.06x-24.55x0.26x0.68x0.47x0.25x-0.06x1.08x2.51x-3.84x0.33x0.26x0.08x-0.70x-1.03x-0.70x-0.10x-2.50x-0.25x
Interest Paid0000469K1.44M2.16M20.8M6.54M200K114K395K202K014K65K80K454K0000000000000
Taxes Paid6.42M6.57M2.7M43.07M452.46M38.02M102.01M16.99M21.05M8.14M4.93M3.88M1.08M04.28M1.04M1.87M246K0000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Biotech R&D spending volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Persistent Disconnect Between Earnings Reality

As reported in financial statements, Azenta consistently generates positive operating cash flow despite recurring net losses, with the OCF/NI ratio frequently showing negative values, such as the -0.08 observed in 2026Q2, highlighting a significant divergence between accounting profitability and actual cash generation capabilities.

The persistent gap between net income and operating cash flow suggests that non-cash charges and accounting adjustments are heavily influencing the bottom line. Investors should monitor whether this cash-generative capacity is sustainable or if it relies on aggressive working capital management that may eventually reverse.

Free Cash Flow Margin Volatility

Based on recent SEC filings, Azenta's free cash flow margins remain highly erratic, fluctuating from a peak of 15.0% in 2025Q1 to a low of -3.6% in 2025Q4, indicating that the company has yet to establish a predictable or stable cash conversion trajectory.

This volatility suggests that the company's operational cash flow is highly sensitive to quarterly fluctuations in project-based revenue and timing of expenses. The inability to maintain consistent positive FCF margins warrants further investigation into the underlying cost structure and the effectiveness of the Ascend transformation program.

Capital Intensity Reflects Infrastructure Burden

According to quarterly data, Azenta maintains a capital expenditure to revenue ratio typically ranging between 4% and 8%, reflecting the ongoing requirement to invest in and maintain its specialized, energy-intensive biorepository and laboratory infrastructure to support its service-based business model.

The consistent level of capital spending suggests that the company is in a phase of heavy asset maintenance rather than rapid expansion. This capital intensity may continue to act as a drag on free cash flow until the company can achieve higher utilization rates across its existing global footprint.

Working Capital Swings Impact Liquidity

As evidenced by the $60.5 million outflow in 2025Q4 followed by a $15.4 million inflow in 2026Q1, Azenta's working capital dynamics appear highly unstable, suggesting that timing differences in customer collections and inventory management are creating significant quarterly noise in cash flow reporting.

These sharp swings in working capital may indicate challenges in managing the cash conversion cycle, particularly within the lumpy Products segment. Investors should monitor whether these fluctuations are merely timing issues or indicative of broader difficulties in aligning cash inflows with the company's operational commitments.

Capital Allocation Shifts Toward Efficiency

Based on historical figures, Azenta has transitioned from aggressive share repurchases, which saw over $660 million deployed in 2024, to a more conservative stance, suggesting a strategic pivot toward preserving cash for operational needs and potential future acquisitions following the divestiture of its semiconductor business.

The cessation of significant buybacks appears to reflect management's focus on internal margin improvement rather than financial engineering. Future capital deployment will likely be scrutinized for its ability to generate a return on invested capital that exceeds the company's current cost of capital.

AZTA — Frequently Asked Questions

Quick answers to the most common questions about buying AZTA stock.

How much cash does Azenta, Inc. (AZTA) generate from operations?

Azenta, Inc. (AZTA) generated $72.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Azenta, Inc.'s free cash flow?

Azenta, Inc. (AZTA) generated $38.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Azenta, Inc.'s capital expenditure (CapEx)?

Azenta, Inc. (AZTA) spent $33.9M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.